Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study

NCT04912648 is registered in ClinicalTrials.gov with Royal College of Surgeons, Ireland as lead sponsor.

NCT NCT04912648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study
Lead sponsor
Royal College of Surgeons, Ireland
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2021
Completion date
August 31, 2031
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperandrogenism, metabolic disease, sex hormones adverse reaction